I"<p><strong>Judging Panel</strong></p>

<p>A panel of judges will evaluate the submissions on the criteria identified below. Judges will be fair and impartial, may not have a personal or financial interest in, or be an employee, officer, director, or agent of, any entity that is a registered participant in the competition, and may not have a familial or financial relationship with an individual who is a registered contestant. The panel will make winner selections based upon the criteria outlined below and in compliance with the HHS Competition Judging Guidelines. Entries not in compliance with the submission requirements outlined above and below will be ineligible for further review and prize award.</p>

<p>The judging panel will not select more than five winners in any state.</p>

<p>The Award Approving Official will be the Deputy Assistant Secretary for Womenâ€™s Health.</p>

<p><strong>Phase 1 Scoring Criteria: Identification of successful programs</strong></p>

<p>All Criteria are scaled 1-10, with 1 being the lowest score on each dimension and 10 being the highest score on each dimension. Scores are weighted by the proportion of each dimension and then aggregated to create a final score. Judging criteria for Phase 1 include (Total Points 100%):</p>

<ul>
  <li>Previously demonstrated effectiveness (statistical power and significance) of the program in: increasing access to, attendance at, and quality of care for postpartum visits, which can be applied to Black or African American and AI/AN beneficiaries enrolled in Medicaid or CHIP: (30%)</li>
  <li>
    <p>Use of evidence-based approaches to target gaps in screening and follow-up rates in one or more of the following: (30%)</p>

    <ul>
      <li>postpartum diabetes, impaired fasting glucose, and/or impaired glucose tolerance in women who had gestational diabetes</li>
      <li>postpartum depression and/or anxiety</li>
      <li>postpartum hypertension</li>
      <li>postpartum access to SUD treatment</li>
    </ul>
  </li>
  <li>
    <p>How the program is innovative at targeting gaps in diagnosis, prevention, and treatment of one or more of the following (40%):</p>

    <ul>
      <li>postpartum diabetes, impaired fasting glucose, and/or impaired glucose tolerance in women who had gestational diabetes</li>
      <li>postpartum depression and/or anxiety</li>
      <li>postpartum hypertension</li>
      <li>postpartum access to SUD treatment</li>
    </ul>
  </li>
</ul>

<p><strong>Phase 2 Scoring Criteria: Awarding the programs that have successfully replicated and/or expanded</strong></p>

<p>All Criteria are scaled 1-10, with 1 being the lowest score on each dimension and 10 being the highest score on each dimension. Scores are weighted by the proportion of each dimension and then aggregated to create a final score. Judging criteria for Phase 2 include (Total Points 100%):</p>

<ul>
  <li>
    <p>Demonstrates effectiveness (statistical power and significance) for Black or African American and AI/AN beneficiaries enrolled in Medicaid or CHIP in one or more of the following (30%):</p>

    <ul>
      <li>Increased screening and follow-up rates for diabetes, impaired fasting glucose, and/or impaired glucose tolerance in postpartum beneficiaries who had gestational diabetes</li>
      <li>Increased screening and follow-up rates for postpartum depression and/or anxiety</li>
      <li>Increased screening and follow-up rates for postpartum hypertension</li>
      <li>Increased access to postpartum SUD treatment</li>
    </ul>
  </li>
  <li>Demonstrates that the program successfully replicated and/or expanded: (1) in another geographic area or a wider geographic area; (2) in another clinical setting; and/or (3) by increasing the size and/or reach of the program: (40%)</li>
  <li>Demonstrates that the program has long-term viability: (30%)</li>
</ul>
:ET